COSCIENS Biopharma Inc. (TSX:CSCI)
8.25
-0.35 (-4.07%)
Nov 19, 2026, 11:10 AM EST
COSCIENS Biopharma Revenue
COSCIENS Biopharma had revenue of $2.52M USD in the quarter ending September 30, 2026, with 70.46% growth. In the year 2025, COSCIENS Biopharma had annual revenue of $7.50M, down -21.79%. That makes COSCIENS Biopharma the 37,557th largest company in the world by revenue and 669th in Canada.
Revenue
$7.50M
Revenue Growth
-21.79%
P/S Ratio
0.59
Revenue / Employee
$267.79K
Employees
28
Market Cap
8.23M CAD
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full COSCIENS Biopharma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.50M | -2.09M | -21.79% |
| Dec 31, 2024 | 9.59M | 2.44M | 34.22% |
| Dec 31, 2023 | 7.14M | -7.43M | -50.98% |
| Dec 31, 2022 | 14.57M | 9.31M | 177.03% |
| Dec 31, 2021 | 5.26M | 1.61M | 44.03% |
| Dec 31, 2020 | 3.65M | 3.12M | 586.47% |
| Dec 31, 2019 | 532.00K | -26.35M | -98.02% |
| Dec 31, 2018 | 26.88M | 25.96M | 2,812.35% |
| Dec 31, 2017 | 923.00K | 12.00K | 1.32% |
| Dec 31, 2016 | 911.00K | 366.00K | 67.16% |
| Dec 31, 2015 | 545.00K | 534.00K | 4,854.55% |
| Dec 31, 2014 | 11.00K | -6.16M | -99.82% |
| Dec 31, 2013 | 6.18M | 4.12M | 200.78% |
| Dec 31, 2012 | 2.05M | -2.65M | -56.37% |
| Dec 31, 2011 | 4.71M | -23.00M | -83.02% |
| Dec 31, 2010 | 27.70M | -35.53M | -56.19% |
| Dec 31, 2009 | 63.24M | 24.76M | 64.35% |
| Dec 31, 2008 | 38.48M | -3.59M | -8.53% |
| Dec 31, 2007 | 42.07M | 3.27M | 8.43% |
| Dec 31, 2006 | 38.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Innovotech | 3.11M |
| Glow Lifetech | 2.31M |
| Rapid Dose Therapeutics | 2.12M |
| Britannia Life Sciences | 406.44K |
| Onco-Innovations | 90.88K |
| Alzai Health | 69.09K |
| Kane Biotech | 38.72K |
COSCIENS Biopharma News
- 6 days ago - COSCIENS Biopharma Earnings release: Q3 2026 - Filings
- 6 days ago - COSCIENS Biopharma Report: Q3 2026 - Filings
- 6 days ago - COSCIENS Biopharma MD&A: Q3 2026 - Filings
- 6 days ago - COSCIENS Biopharma Inc. Reports Q3 2026 Results and Provides Update On Convertible Debenture Offering - GlobeNewsWire
- 6 days ago - COSCIENS Biopharma Slides: Corporate presentation - Filings
- 4 weeks ago - COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING - GlobeNewsWire
- 5 weeks ago - COSCIENS Biopharma Slides: Corporate presentation - Filings
- 2 months ago - COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING - GlobeNewsWire